Triggering ovulation with leuprolide acetate (LA) instead of human chorionic gonadotropin (hCG) after the use of ganirelix for in vitro fertilization-embryo transfer (IVF-ET) does not compromise cycle outcome and may prevent ovarian hyperstimulation syndrome.
- 30 September 2001
- journal article
- abstracts
- Published by Elsevier in Fertility and Sterility
- Vol. 76 (3) , S93
- https://doi.org/10.1016/s0015-0282(01)02277-4
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: